Skip to content
10-Q

Quarterly Report

COLLEGIUM PHARMACEUTICAL, INC COLL

0001558370-25-006960

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 30, 2025 32.14M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $486.71M
Current Liabilities Q1 2025 · Dec 31, 2024 $509.51M
Total Liabilities Q1 2025 · Mar 31, 2025 $1.4B
Total Liabilities Q1 2025 · Dec 31, 2024 $1.43B
Current Assets Q1 2025 · Mar 31, 2025 $527.55M
Current Assets Q1 2025 · Dec 31, 2024 $482.26M
Total Assets Q1 2025 · Mar 31, 2025 $1.63B
Total Assets Q1 2025 · Dec 31, 2024 $1.66B
Cash And Equivalents Q1 2025 · Dec 31, 2024 $70.57M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $228.61M
Shares Diluted Q1 2025 · Mar 31, 2024 41.44M sh
Capex Q1 2025 · Mar 31, 2024 $568K
Operating Cash Flow Q1 2025 · Mar 31, 2024 $61.94M
Stockholders Equity Q1 2025 · Mar 31, 2024 $222.17M
Stockholders Equity Q1 2025 · Dec 31, 2023 $195.43M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.71
Eps Basic Q1 2025 · Mar 31, 2024 $0.86
Sga Expense Q1 2025 · Mar 31, 2024 $41.98M
Net Income Q1 2025 · Mar 31, 2024 $27.71M
Operating Income Q1 2025 · Mar 31, 2024 $49.47M
Gross Profit Q1 2025 · Mar 31, 2024 $91.46M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $53.47M
Revenue Q1 2025 · Mar 31, 2024 $144.92M